ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,113Medicare Part D Prescriptions Filled, Including Refills

Rank: 75 out of 278

$595K Total Retail Price of All Prescriptions

Rank: 78 out of 278

463 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 463 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 463 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 7,937 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
LEVOTHYROXINE SODIUM 468 408 1 2
FUROSEMIDE 384 350 2 6
LISINOPRIL 308 242 3 5
SIMVASTATIN 307 240 4 4
AMLODIPINE BESYLATE 274 234 5 7
OMEPRAZOLE 266 207 6 3
WARFARIN SODIUM 253 231 7 11
CRESTOR 246 185 8 19
METOPROLOL SUCCINATE 241 178 9 10
HYDROCODONE-ACETAMINOPHEN 239 123 S3 10 1
NEXIUM 186 119 11 14
TRAMADOL HCL 176 155 12 22
HYDROCHLOROTHIAZIDE 156 99 13 15
METFORMIN HCL 152 115 14 8
ATENOLOL 149 134 15 18
DIOVAN 146 128 16 43
POTASSIUM CHLORIDE 138 131 17 17
ATORVASTATIN CALCIUM 123 92 18 13
METOPROLOL TARTRATE 119 100 19 9
DEXILANT 118 70 20 84
DIOVAN HCT 104 91 21 110
RANITIDINE HCL 99 83 22 27
CITALOPRAM HBR 94 51 23 21
SERTRALINE HCL 93 65 24 25
ESCITALOPRAM OXALATE 89 63 25 63
PREDNISONE 88 70 26 35
GABAPENTIN 83 54 27 12
ZOLPIDEM TARTRATE 83 58 27 26
PROAIR HFA 81 40 29 34
BYSTOLIC 76 55 30 114
ALLOPURINOL 75 67 31 38
BENICAR 72 59 32 134
LANTUS 69 64 33 56
CLOPIDOGREL 68 56 34 20
ADVAIR DISKUS 68 52 34 45
JANUVIA 65 52 36 53
EXFORGE 65 43 36 187
LOVASTATIN 64 50 38 52
ISOSORBIDE MONONITRATE ER 64 64 38 33
LISINOPRIL-HYDROCHLOROTHIAZIDE 61 58 40 31
AZITHROMYCIN 61 54 40 39
BENICAR HCT 59 49 42 179
DILTIAZEM 24HR ER 58 57 43 121
SINGULAIR 58 38 43 60
DIGOXIN 58 53 43 40
PANTOPRAZOLE SODIUM 58 54 43 36
DONEPEZIL HCL 57 57 47 29
TAMSULOSIN HCL 55 47 48 32
GLIPIZIDE 55 45 48 55
AMLODIPINE BESYLATE-BENAZEPRIL 54 52 50 77
TRAZODONE HCL 53 14 51 47
LOSARTAN POTASSIUM 53 45 51 24
AZOR 52 43 53 249
CARBIDOPA-LEVODOPA 51 39 54 113
LEVOFLOXACIN 51 40 54 66
DILTIAZEM 24HR CD 50 50 56 95
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.